Matsunaga K - Search Results

1

Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: human liver enzymatic activation and its action in warfarin-poisoned human liver.

Takata J, Karube Y, Hanada M, Matsunaga K, Iwasaki H. Takata J, et al. Among authors: matsunaga k. Biol Pharm Bull. 1999 Feb;22(2):172-8. doi: 10.1248/bpb.22.172. Biol Pharm Bull. 1999. PMID: 10077437 Free article.

2

Prodrugs for systemic bioreductive activation-independent delivery of phyllohydroquinone, an active form of phylloquinone (vitamin K1). 1: Preparation and in vitro evaluation.

Takata J, Karube Y, Matsunaga K, Hanada M, Hidaka R, Matsushima Y. Takata J, et al. Among authors: matsunaga k. Biol Pharm Bull. 1999 Dec;22(12):1347-54. doi: 10.1248/bpb.22.1347. Biol Pharm Bull. 1999. PMID: 10746168 Free article.

3

Vitamin K prodrugs: 1. Synthesis of amino acid esters of menahydroquinone-4 and enzymatic reconversion to an active form.

Takata J, Karube Y, Hanada M, Matsunaga K, Matsushima Y, Sendo T, Aoyama T. Takata J, et al. Among authors: matsunaga k. Pharm Res. 1995 Jan;12(1):18-23. doi: 10.1023/a:1016274201137. Pharm Res. 1995. PMID: 7724483

4

Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery.

Takata J, Karube Y, Hanada M, Matsunaga K, Matsushima Y, Sendo T, Oishi R. Takata J, et al. Among authors: matsunaga k. Pharm Res. 1995 Dec;12(12):1973-9. doi: 10.1023/a:1016208409992. Pharm Res. 1995. PMID: 8786976

5

Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.

Karube Y, Katsuno K, Takata J, Matsunaga K, Haruno M, Kuroki M, Arakawa F, Matsuoka Y, Kanda H. Karube Y, et al. Among authors: matsunaga k. Nucl Med Biol. 1996 Aug;23(6):753-9. doi: 10.1016/0969-8051(96)00067-4. Nucl Med Biol. 1996. PMID: 8940717

6

Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody.

Karube Y, Katsuno K, Ito S, Matsunaga K, Takata J, Kuroki M, Murakami M, Matsuoka Y. Karube Y, et al. Among authors: matsunaga k. Ann Nucl Med. 1999 Dec;13(6):407-13. doi: 10.1007/BF03164935. Ann Nucl Med. 1999. PMID: 10656275

7

Tumor-specific accumulation of 125I-labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autoradiography and immunostaining.

Haruno M, Kuroki M, Matsunaga K, Takata J, Karube Y, Senba T, Murakami M, Arakawa F, Kuwahara M, Ozaki H, Matsuoka Y, Okazaki M, Kanda H. Haruno M, et al. Among authors: matsunaga k. Nucl Med Biol. 1996 Aug;23(6):821-6. doi: 10.1016/0969-8051(96)00081-9. Nucl Med Biol. 1996. PMID: 8940726

8

Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle.

Matsunaga K, Mashiba H. Matsunaga K, et al. Eur Cytokine Netw. 1992 May-Jun;3(3):307-11. Eur Cytokine Netw. 1992. PMID: 1498261

9

Enhancement of radiosensitizing effect of the nitroimidazole derivative RK28 on the proliferation of MethA tumor cells in combined use with diethyldithiocarbamate.

Mashiba H, Matsunaga K, Hata K. Mashiba H, et al. Among authors: matsunaga k. Life Sci. 1991;49(19):1419-25. doi: 10.1016/0024-3205(91)90394-q. Life Sci. 1991. PMID: 1658511

10

Inhibition of neuronal dopamine uptake by some antiallergic drugs.

Matsunaga K, Sato T, Shuto H, Tsuruta Y, Suemaru K, Gomita Y, Oishi R. Matsunaga K, et al. Eur J Pharmacol. 1998 Jun 5;350(2-3):165-9. doi: 10.1016/s0014-2999(98)00253-2. Eur J Pharmacol. 1998. PMID: 9696404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,396 results

Search Page

Filters